Trending: Pfizer's 2024 Guidance Disappoints
13 Dezembro 2023 - 12:28PM
Dow Jones News
9:58 ET--Pfizer is one of the most mentioned companies in the
U.S. across all news items in the last 12 hours, according to
Factiva data. The drugmaker issued 2024 guidance that fell short of
Wall Street's expectations and warned that revenue could decline
next year amid a continued slowdown in demand for its Covid-19
vaccine and related products. Pfizer shares fall more than 9% and
hit a 52-week low. Dow Jones & Co. owns Factiva.
(colin.kellaher@wsj.com)
(END) Dow Jones Newswires
December 13, 2023 10:13 ET (15:13 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Pfizer (NYSE:PFE)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024